Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
150 participants
OBSERVATIONAL
2024-12-25
2026-01-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intrapartum Rapid GBS Testing in Patients Presenting With Threatened Preterm Labor
NCT02511444
Colonization with Group B Streptococcus During Pregnancy
NCT03671486
Real-Time PCR for the Detection of Vaginal Group B Streptococcus Carriage: a Medico-Economic Study
NCT00920530
Development and Optimization of a GBS Diagnostic Test
NCT00322829
Rapid Detection of Group B Streptococcus (Strep)-Labor and Delivery Study
NCT00330642
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregnant women after 34 wks with PROM
To provide ampicillin sulbactam to pregnant women with premature rupture of membrane
To provide ampicillin sulbactam tonpregnant women with premature rupture of membrane after 34 wks gestation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
To provide ampicillin sulbactam to pregnant women with premature rupture of membrane
To provide ampicillin sulbactam tonpregnant women with premature rupture of membrane after 34 wks gestation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* emergency conditions
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dina Mohamed Kamel
Dina mohamedkamel
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Sherif Abdelmeged badran
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GBS WITH PROM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.